Analysts Predict Slower Rollout but Ultimate Victory for Casgevy in Race with Lyfgenia
Pictured: An illustration of a semi-truck hauling an IV bag/Nicole Bean for BioSpace After winning FDA approvals to treat sickle cell disease and beta thalassemia, Vertex Pharmaceuticals and partner CRISPR Therapeutics are working to expand the number …